Cadila Pharmaceuticals's Drug for Rheumatoid Arthritis Gets U.S. Okay Published: Sep 25, 2007 MUMBAI (Reuters) - Cadila Healthcare Ltd said on Tuesday it received approval from U.S. health regulators for its hydroxychloroquine sulphate tablets. Related links Reuters This will open in a new window Email this Facebook Twitter LinkedIn Pinterest Reddit Back to news